Literature DB >> 24391213

Identification of hypoxia-inducible factor HIF-1A as transcriptional regulator of the A2B adenosine receptor during acute lung injury.

Tobias Eckle1, Emily M Kewley, Kelley S Brodsky, Eunyoung Tak, Stephanie Bonney, Merit Gobel, Devon Anderson, Louise E Glover, Ann K Riegel, Sean P Colgan, Holger K Eltzschig.   

Abstract

Although acute lung injury (ALI) contributes significantly to critical illness, resolution often occurs spontaneously through endogenous pathways. We recently found that mechanical ventilation increases levels of pulmonary adenosine, a signaling molecule known to attenuate lung inflammation. In this study, we hypothesized a contribution of transcriptionally controlled pathways to pulmonary adenosine receptor (ADOR) signaling during ALI. We gained initial insight from microarray analysis of pulmonary epithelia exposed to conditions of cyclic mechanical stretch, a mimic for ventilation-induced lung disease. Surprisingly, these studies revealed a selective induction of the ADORA2B. Using real-time RT-PCR and Western blotting, we confirmed an up to 9-fold induction of the ADORA2B following cyclic mechanical stretch (A549, Calu-3, or human primary alveolar epithelial cells). Studies using ADORA2B promoter constructs identified a prominent region within the ADORA2B promoter conveying stretch responsiveness. This region of the promoter contained a binding site for the transcription factor hypoxia-inducible factor (HIF)-1. Additional studies using site-directed mutagenesis or transcription factor binding assays demonstrated a functional role for HIF-1 in stretch-induced increases of ADORA2B expression. Moreover, studies of ventilator-induced lung injury revealed induction of the ADORA2B during ALI in vivo that was abolished following HIF inhibition or genetic deletion of Hif1a. Together, these studies implicate HIF in the transcriptional control of pulmonary adenosine signaling during ALI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24391213      PMCID: PMC3946986          DOI: 10.4049/jimmunol.1100593

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.

Authors:  Mary A Selak; Sean M Armour; Elaine D MacKenzie; Houda Boulahbel; David G Watson; Kyle D Mansfield; Yi Pan; M Celeste Simon; Craig B Thompson; Eyal Gottlieb
Journal:  Cancer Cell       Date:  2005-01       Impact factor: 31.743

3.  The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively.

Authors:  B N Cronstein; L Daguma; D Nichols; A J Hutchison; M Williams
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism.

Authors:  Holger K Eltzschig; Linda F Thompson; Jorn Karhausen; Richard J Cotta; Juan C Ibla; Simon C Robson; Sean P Colgan
Journal:  Blood       Date:  2004-08-19       Impact factor: 22.113

5.  Analysis of A2a receptor-deficient mice reveals no significant compensatory increases in the expression of A2b, A1, and A3 adenosine receptors in lymphoid organs.

Authors:  Dmitriy E Lukashev; Patrick T Smith; Charles C Caldwell; Akio Ohta; Sergey G Apasov; Michail V Sitkovsky
Journal:  Biochem Pharmacol       Date:  2003-06-15       Impact factor: 5.858

6.  Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung.

Authors:  A Y Yu; M G Frid; L A Shimoda; C M Wiener; K Stenmark; G L Semenza
Journal:  Am J Physiol       Date:  1998-10

Review 7.  Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

Authors:  Michail V Sitkovsky; Dmitriy Lukashev; Sergey Apasov; Hidefumi Kojima; Masahiro Koshiba; Charles Caldwell; Akio Ohta; Manfred Thiel
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

8.  Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens.

Authors:  Nadine Werth; Christiane Beerlage; Christian Rosenberger; Amir S Yazdi; Markus Edelmann; Amro Amr; Wanja Bernhardt; Christof von Eiff; Karsten Becker; Andrea Schäfer; Andreas Peschel; Volkhard A J Kempf
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

9.  Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia.

Authors:  Linda F Thompson; Holger K Eltzschig; Juan C Ibla; C Justin Van De Wiele; Regina Resta; Julio C Morote-Garcia; Sean P Colgan
Journal:  J Exp Med       Date:  2004-12-06       Impact factor: 14.307

10.  Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors.

Authors:  Holger K Eltzschig; Juan C Ibla; Glenn T Furuta; Martin O Leonard; Kenneth A Jacobson; Keiichi Enjyoji; Simon C Robson; Sean P Colgan
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

View more
  55 in total

Review 1.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

2.  Lung injury pathways: Adenosine receptor 2B signaling limits development of ischemic bronchiolitis obliterans organizing pneumonia.

Authors:  John C Densmore; Terry R Schaid; Paul M Jeziorczak; Meetha Medhora; Said Audi; Shraddha Nayak; John Auchampach; Melinda R Dwinell; Aron M Geurts; Elizabeth R Jacobs
Journal:  Exp Lung Res       Date:  2017-03-07       Impact factor: 2.459

3.  HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis.

Authors:  Kemly Philip; Tingting Weng Mills; Jonathan Davies; Ning-Yuan Chen; Harry Karmouty-Quintana; Fayong Luo; Jose G Molina; Javier Amione-Guerra; Neeraj Sinha; Ashrith Guha; Holger K Eltzschig; Michael R Blackburn
Journal:  FASEB J       Date:  2017-07-12       Impact factor: 5.191

4.  Alveolar Epithelial A2B Adenosine Receptors in Pulmonary Protection during Acute Lung Injury.

Authors:  Sandra Hoegl; Kelley S Brodsky; Michael R Blackburn; Harry Karmouty-Quintana; Bernhard Zwissler; Holger K Eltzschig
Journal:  J Immunol       Date:  2015-07-17       Impact factor: 5.422

Review 5.  Hypoxia signaling during acute lung injury.

Authors:  Christine U Vohwinkel; Sandra Hoegl; Holger K Eltzschig
Journal:  J Appl Physiol (1985)       Date:  2015-05-14

Review 6.  Targeting Hypoxia Signaling for Perioperative Organ Injury.

Authors:  Xiaoyi Yuan; Jae W Lee; Jessica L Bowser; Viola Neudecker; Srikanth Sridhar; Holger K Eltzschig
Journal:  Anesth Analg       Date:  2018-01       Impact factor: 5.108

7.  Immunologic Consequences of Hypoxia during Critical Illness.

Authors:  Harmke D Kiers; Gert-Jan Scheffer; Johannes G van der Hoeven; Holger K Eltzschig; Peter Pickkers; Matthijs Kox
Journal:  Anesthesiology       Date:  2016-07       Impact factor: 7.892

Review 8.  Purinergic regulation of the immune system.

Authors:  Caglar Cekic; Joel Linden
Journal:  Nat Rev Immunol       Date:  2016-03       Impact factor: 53.106

9.  A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive Dysfunction.

Authors:  Jennifer Gile; Yoshimasa Oyama; Sydney Shuff; Tobias Eckle
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

10.  Cutting Edge: Human Vagus Produces Specialized Proresolving Mediators of Inflammation with Electrical Stimulation Reducing Proinflammatory Eicosanoids.

Authors:  Charles N Serhan; Xavier de la Rosa; Charlotte C Jouvene
Journal:  J Immunol       Date:  2018-10-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.